Skip to Content

180 mg WATSON 663 (Diltiazem CD 180 mg/24 hours)

Pill imprint 180 mg WATSON 663 has been identified as Diltiazem hydrochloride CD 180 mg/24 hours.

Diltiazem is used in the treatment of atrial fibrillation; high blood pressure; supraventricular tachycardia; atrial flutter; raynaud's syndrome (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 180 mg/24 hours is not a controlled substance under the Controlled Substance Act (CSA).

Diltiazem hydrochloride CD 180 mg/24 hours 180 mg WATSON 663
Diltiazem hydrochloride CD
180 mg WATSON 663
180 mg/24 hours
Pink & White
Prescription only
Drug Class:
Calcium channel blocking agents
Group IV antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Watson Pharmaceuticals

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.